General
Preferred name
METHYLPREDNISOLONE HEMISUCCINATE
Synonyms
methylprednisolone succinate ()
6¦Á-Methylprednisolone 21-hemisuccinate (sodium salt) ()
6??-Methylprednisolone 21-hemisuccinate (sodium salt) ()
U-9088, 6??-Methylprednisolone 21-hemisuccinate Sodium ()
Methylprednisolone succinate (sodium) ()
METHYLPREDNISOLONE SODIUM SUCCINATE ()
Methylprednisolone hydrogen succinate (sodium) ()
Methylprednisolone hydrogen succinate ()
U-9088, 6¦Á-Methylprednisolone 21-hemisuccinate Sodium ()
6α-Methylprednisolone 21-Hemisuccinate Sodium Salt ()
Methylprednisolone succinate ()
NSC-48989 ()
Solu-medrol ()
Min-I-Mix ()
Solu-Medrone ()
A-Methapred ()
Urbasone ()
Methylprednisolone 21-succinate sodium salt ()
Methylprednisolone ()
6.alpha.-Methylprednisolone 21-hemisuccinate ()
6?-Methylprednisolone 21-hemisuccinate (sodium salt) ()
P&D ID
PD013851
CAS
2921-57-5
2375-03-3
Tags
prodrug
natural product
drug
available
Approved by
FDA
First approval
1959
Drug Status
approved
Max Phase
Phase 4
Drug indication
Adrenocortical Steroid,Glucocorticoid
Glucocorticoid
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
6α-Methylprednisolone 21-hemisuccinate, a derivative of prednisolone, is a kind of glucocorticoids. It has been developed for having longer half-life than that of Prednisolone and the potential anti-inflammatory effects.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
12
BOC Sciences Bioactive Compounds
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
NPC Screening Collection
Selleckchem Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
46
Properties
(calculated by RDKit )
Molecular Weight
474.23
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
3
Rotatable Bonds
6
Ring Count
4
Aromatic Ring Count
0
cLogP
2.22
TPSA
138.2
Fraction CSP3
0.69
Chiral centers
8.0
Largest ring
6.0
QED
0.5
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Disease Area
endocrinology, rheumatology, dermatology, pulmonary, allergy, infectious disease, ophthalmology, gastroenterology, hematology, neurology/psychiatry
Indication
hypercalcemia, thyroiditis, osteoarthritis, rheumatoid arthritis, seborrheic dermatitis, asthma, allergic rhinitis, shingles, conjunctivitis, ulcerative colitis, enteritis, anemia, multiple sclerosis, mycosis
MOA
Glucocorticoid Receptor agonist
Pathway
Anti-infection
Immunology/Inflammation
Vitamin D Related/Nuclear Receptor
Target
Bacterial
Glucocorticoid Receptor
Immunology & Inflammation related
Solubility
Soluble in DMSO (Slightly), Methanol (Slightly)
Source data